Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $65.07 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.47 | 1 | $0 (2018) |
| Allergan Inc. | $11.60 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $53.47 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53.47) |
| 2017 | $11.60 | 1 | Allergan Inc. ($11.60) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $53.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/27/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 238 | 252 | $78,641 | $20,634 |
| 2022 | 8 | 240 | 255 | $77,442 | $19,459 |
| 2021 | 6 | 223 | 248 | $57,204 | $19,909 |
| 2020 | 8 | 264 | 322 | $58,503 | $18,609 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $14,759 | $3,699 | 25.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 100 | 111 | $10,103 | $3,586 | 35.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $9,381 | $3,555 | 37.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $11,100 | $2,251 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $4,791 | $1,846 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,198 | $1,460 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $3,420 | $1,286 | 37.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $9,420 | $1,117 | 11.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $7,697 | $932.88 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,772 | $900.80 | 32.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 20 | $17,364 | $4,037 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $9,010 | $3,009 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 82 | 90 | $8,192 | $3,006 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 31 | $7,818 | $2,781 | 35.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $16,485 | $2,375 | 14.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $7,250 | $2,063 | 28.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 15 | $8,247 | $1,120 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 18 | $3,078 | $1,067 | 34.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 19 | 19 | $16,496 | $4,012 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 40 | $10,087 | $3,992 | 39.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 78 | 90 | $8,096 | $3,586 | 44.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $9,116 | $3,382 | 37.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $7,970 | $2,791 | 35.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 33 | $5,439 | $2,146 | 39.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 99 | 134 | $10,050 | $4,259 | 42.4% |
About Dr. Stacy Harbin, MD
Dr. Stacy Harbin, MD is a Surgery healthcare provider based in Port St Joe, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275639254.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacy Harbin, MD has received a total of $65.07 in payments from pharmaceutical and medical device companies, with $53.47 received in 2018. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($65.07).
As a Medicare-enrolled provider, Harbin has provided services to 965 Medicare beneficiaries, totaling 1,077 services with total Medicare billing of $78,610. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Surgery
- Location Port St Joe, FL
- Active Since 09/16/2006
- Last Updated 07/27/2021
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1275639254
Products in Payments
- PRADAXA (Drug) $53.47
- AVYCAZ (Drug) $11.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.